ArticleResearch square2026
Long-term cancer survivor awareness and learning preferences for cardio- oncologic risks: A qualitative study.
Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Purpose: To understand general CVD risk awareness and learning preferences of cancer survivors, with particular attention to the learning needs of long-term (>5 year) survivors. Methods: We performed a qualitative sub-study of participants recruited from 14 community educational and health events in an underserved are of Dallas, TX from July 2023 - May 2024. Recorded interviews were transcribed verbatim, analyzed in two phases (framework analysis then systematic coding) to identify themes. Results: Twenty-six cancer survivors ranging in age from 30 to 82 (average age of 64.5 years) were interviewed, a large majority being long-term (>5 year) survivors and African American. Participants had diverse types of cancer, predominantly breast or prostate. Triangulation methods produced 3 themes: (1) Although a majority (73%) of participants self-reported knowledge about CVD risks after cancer treatment, narratives revealed a substantial lack of clarity about individual cardio-oncologic risk factors, such as the latent risks from chemotherapy or radiation. (2) Participants expressed trust and satisfaction with communications from their cancer treatment team with most (77%) stating that greater CVD risk understanding would not have changed their oncology treatment decisions. (3) For learning about CVD risks, participants preferred conversations with healthcare providers at multiple time points, before and after oncology treatment, as well as written materials that could be preserved and consulted later in the survivorship period. Conclusion: Survivors initially over-estimated their knowledge of CVD risks related to their cancer treatment and relied on their clinicians to raise concerns. Survivors' awareness of CVD risks may be improved through targeted communications by clinicians, particular for long-term survivors, supplemented by durable reference materials. Greater attention to long-term CVD risk awareness in cancer survivors may improve CVD prevention among cancer survivors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.